Top news of the week: 06.10.2021.
Companies And Industries
Biopharma Can Dispel the Fog of Data
Snthesis describes how data can be aggregated, connected, and harmonized to optimize workflows and reveal scientific insights.
Good Day BIO: USTR's China Strategy
The U.S. Trade Representative made a major policy speech yesterday on the administration’s approach to China—we tell you what biotech needs to know. Also, a recent report looks at ...
Vedanta touts positive new data for its C. diff microbiome therapeutic — but is it too late?
Vedanta revealed positive new data for its C. difficile microbiome therapeutic. But is it too late an entrant into the field?
Adventures Leading to a Paradigm Shift in Healthcare
Advances in sequencing, big data technology, systems biology, and blood analysis open new paths to wellness.
COVID-19 Update: J&J to Request Booster Authorization, Merck Antiviral Review a Priority
Johnson & Johnson is expected to ask the U.S. Food and Drug Administration to authorize a booster for its one-shot COVID-19 vaccine this week.
Merck confirms $11.5bn Acceleron takeover deal
Rumours of big pharma interest in Acceleron Pharma proved well-founded, as Merck breaks cover with an $11.5bn takeover deal
Aurion Biotech Industrializing Ophthalmologic Cell-Based Therapy
The company is focusing on improving shelf life and “turn-keying” treatment protocols.
Xencor expands Janssen partnership with $1.31B licensing and development deal
Xencor Inc. and Janssen Biotech Inc., already partners on the development of bispecific antibodies against CD28 for prostate cancer, have reached a second agreement licensing to Janssen ...